Lactiplantibacillus plantarum Q180
Lactiplantibacillus plantarum Q180 has been studied in the context of lipid metabolism and body composition. In vitro screening has examined lipase inhibitory activity, and animal studies using high-fat diet models have examined body weight, liver lipid profiles, and gut microbiota and intestinal barrier changes. A 2026 human randomized controlled trial evaluated a combination product (CKDB-322) containing Q180 alongside the microalgae Phaeodactylum tricornutum in the context of body fat in overweight adults; the multi-component design means Q180's individual contribution cannot be isolated from that trial. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 9 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 7 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
10 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 42639947 →Lactiplantibacillus plantarum Q180 Mitigates Early High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Gut–Liver Axis Inflammation and Barrier Integrity· Journal of Medicinal Food · 2026
-
[2]
PMID 41599863 →Efficacy and Safety of CKDB-322, a Combination of Lactiplantibacillus plantarum Q180 and Phaeodactylum tricornutum, for Reducing Body Fat and Abdominal Adiposity in Overweight Adults· Nutrients · 2026
-
[3]
Source →Lactiplantibacillus plantarum Q180 improves early HFD-induced MASLD by modulating gut–liver axis inflammation and barrier integrity· Research Square · 2026
-
[4]
PMID 41574946 →Lactiplantibacillus plantarum Q180 supplementation restores high-fat diet-induced gut dysbiosis and intestinal barrier dysfunction in mice· Journal of Applied Microbiology · 2026
-
[5]
PMID 40869311 →Synergistic Anti-Obesity Effects of Lactiplantibacillus plantarum Q180 and Phaeodactylum tricornutum (CKDB-322) in High-Fat-Diet-Induced Obese Mice· International Journal of Molecular Sciences · 2025